PDK1 and cancer: DCA, by inhibiting the E1α subunit of pyruvate dehydrogenase kinase-1 (PDK1), keeps the PDH complex in its unphosphorylated active form, facilitates the oxidative removal of pyruvate and the mitochondrial oxidation of glucose, and decreases the amount of lactic acid in cancer cells and their microenvironment [24,25].